KRAS and non-small cell lung carcinoma: Comprehensive genomic profiling in SMARCA4-deficient NSCLC commonly identifies mutations in critical oncogenes such as TP53 (80%), LRP1B (40%), STK11 (27%), KEAP1 (27%), and KRAS (20%).